Literature DB >> 11090913

The psychopharmacology of tachykinin NK-3 receptors in laboratory animals.

M Massi1, I Panocka, G de Caro.   

Abstract

The present article reviews the studies so far published on the psychopharmacological effects mediated by tachykinin NK-3 receptors in laboratory animals. Central administration of NK-3 receptor agonists has been reported to attenuate alcohol intake in alcohol-preferring rats and to evoke conditioned place preference. These findings suggest that NK-3 receptors may affect reward processes to drugs of abuse. Anxiolytic-like and antidepressant-like effects have been previously reported for NK-1 receptor antagonists, and anxiolytic-like effects for NK-2 receptor antagonists. More recently, it has been shown that NK-3 receptor agonists have anxiolytic-like and antidepressant-like effects in mice and rats, while an NK-3 receptor antagonist was reported to be anxiogenic in mice. These findings indicate that different TK receptor subtypes may be involved in anxiolytic-like and antidepressant-like effects in laboratory animals and raise interest for the possible role of NK-3 receptors in the control of anxiety and depression in man.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090913     DOI: 10.1016/s0196-9781(00)00291-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.

Authors:  Gabriel S Bassi; Ana C Broiz; Margarete Z Gomes; Marcus L Brandão
Journal:  Psychopharmacology (Berl)       Date:  2008-12-18       Impact factor: 4.530

Review 2.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease.

Authors:  James G Greene
Journal:  J Physiol       Date:  2006-06-01       Impact factor: 5.182

Review 4.  Neurokinin receptors in drug and alcohol addiction.

Authors:  Jesse R Schank
Journal:  Brain Res       Date:  2020-02-15       Impact factor: 3.252

Review 5.  Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  Elaine C Gavioli; Girolamo Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

6.  The tachykinin receptor 3 is associated with alcohol and cocaine dependence.

Authors:  Tatiana Foroud; Leah Flury Wetherill; John Kramer; Jay A Tischfield; John I Nurnberger; Marc A Schuckit; Xiaoling Xuei; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2008-04-15       Impact factor: 3.455

7.  Activation of tachykinin, neurokinin 3 receptors affects chromatin structure and gene expression by means of histone acetylation.

Authors:  Amit Thakar; Elise Sylar; Francis W Flynn
Journal:  Peptides       Date:  2012-09-15       Impact factor: 3.750

8.  Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity.

Authors:  Chinwe A Nwaneshiudu; Ellen M Unterwald
Journal:  Neuropharmacology       Date:  2009-06-03       Impact factor: 5.250

9.  Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats.

Authors:  Karl Ebner; Nadia M Rupniak; Alois Saria; Nicolas Singewald
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.